A novel surgical method of penile girth enhancement for patients with small penis

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR1900022302

Enrollment

Unknown

Registered

2019-04-03

Start date

2019-05-01

Completion date

Unknown

Last updated

2019-04-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

small penis

Interventions

Case series:Autologous scrotal fascia transposition

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: 1) complaints of dissatisfied penis size and a clinical diagnosis of SPS; 2) aged 18 to 60 years old; 3) knowledge of the trial procedures and agreement by written consent.

Exclusion criteria

Exclusion criteria: 1) no previous surgical penis extension operations; 2) no penis urethra abnormalities and no blood creatinine abnormalities (eg, high or low alanine transaminase or aspartate transaminase levels), spirit disease,excessive sex vanity, homosexuality, or sex pouring wrong disease; 3) alcohol abuse, cancer, diabetes, or erectile dysfunction; 4) any ethical or other reason according to the researchers that might influence the experimental results.

Design outcomes

Primary

Measure	Time frame
Girth enhancement;length enhancement;	—

Secondary

Measure	Time frame
subjective satisfaction;adverse events;	—

Countries

China

Contacts

Public ContactXinjun Su

654060549@qq.com+86 15102792823

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026